JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 42(2008) N 4 p. 514-520;
A.V. Marakhonov1, A.V. Baranova1,2, M.Yu. Skoblov1

Antisense regulation of human gene MAP3K13: True phenomenon or artifact?

1Research Center for Medical Genetics, Russian Academy of Medical Sciences, Moscow, 115478, Russia
2Molecular and Microbiology Department, College of Science, George Mason University, Fairfax, VA, 22030, USA
Received - 2008-01-16; Accepted - 2008-01-31

Antisense regulation of gene expression is a widespread but poorly understood mechanism of gene expression regulation. The potential role of antisense transcripts in tumorigenesis is most intriguing for functional research. Here we experimentally characterize an antisense mRNA asLZK overlapping the human MAP3K13/LZK gene that is involved in the mitogenesis-related JNK/SAPK signal transduction pathway. According to the functional annotation of the human genome, asLZK transcript (LOC647276) is expressed at the relatively high level and overrepresented in tumor samples. To our surprise, experimental study of human asLZK revealed that this sequence is not expressed, but represents a silent pseudogene of ribosomal protein L4 encoding gene RPL4. This pseudogene resulted from relatively recent retroposition of RPL4 mRNA into the first intron of MAP3K13 gene and does not participate in the regulation of MAP3K13 expression. This study stresses that, after initial in silico mapping efforts, experimental verification of the expression landscape is warranted.

antisense regulation of gene expression, MAP3K13, pseudogene, RPL4, genome annotation



JMB-FOOTER RAS-JOURNALS